Confident Moves: See if a web-based program helps adults with obesity stay more active

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial evaluates the Confident Moves intervention, a secure online program designed to promote daily physical activity in adults with obesity, against standard obesity care. It uses device-measured activity data and a whole-person health index to gauge impact. Participants are adults aged 18-64 with BMI 25 kg/m2 or higher, who have access to a suitable device and are willing to wear a wrist accelerometer for two 7-day periods. The intervention builds confidence, knowledge, and skills for physical activity across everyday settings in a self-paced online format. Prior pilot testing indicated the approach is acceptable and feasible, and refinements were made to study procedures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18-64 years
* Body Mass Index (BMI) ≥ 25 kg/m²
* Access to a technological device (e.g., computer, smartphone) capable of supporting the online intervention
* Not currently enrolled in another physical activity (PA) intervention (except standard obesity care programs at participating centers)
* Willingness to wear a wrist worn accelerometer for two separate 7 day monitoring periods
* Willingness to respond to study related communications (e.g., email, text, phone call)

Exclusion Criteria:

\- Failure to meet one or more of the inclusion criteria

Where it's running

• Iowa Specialty Hospital
  Des Moines, Iowa, United States Recruiting

Study contacts

• Study coordinator: Seungmin Lee, PhD
• Email: seunglee@iastate.edu
• Phone: 515-294-8257

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

• Monthly dose of PF-08653944 vs placebo in Chinese adults who are overweight or obese

  This study tests whether berobenatide (PF-08653944) given once a month helps adults in China lose weight compared with a placebo.

  Recruiting Phase 3 Pfizer · Hefei, Anhui and 5 other locations · NCT07874633

• FutureShape Family: a family-based weight-management program with semaglutide for children and parents

  This trial tests whether a family-centered program that combines a prescription medication (semaglutide) with lifestyle support and app-based coaching can help adults with obesity and their children who are overweight/obese.

  Recruiting Phase 4 University of Copenhagen · Copenhagen · NCT07872904

• Home self-administration of a weight-management medicine with an autoinjector in adults who are overweight or obese

  This study tests whether adults who are overweight or have obesity can successfully self-administer maridebart cafraglutide at home using an autoinjector.

  Recruiting at 25 sites Phase 3 Amgen · San Diego, California and 24 other locations · NCT07871409

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.